Showing results (61-70 of 130) with videos related to

Sort By:
Pageof 13
European Journal of Haematology|December 14, 2021
Anti-thymocyte Globulin and Post-Transplant Cyclophosphamide do not abrogate the inferior outcome risk conferred by human leukocyte antigen-A and -B mismatched donorsIgor Novitzky-Basso, Mats Remberger, Carol Chen, et al.
British Journal of Haematology|August 27, 2025
A decade of experience using ATG and PTCy for graft-versus-host disease prophylaxis in matched unrelated donor allogeneic haematopoietic cell transplantationNihar Desai, Sergio Rodriguez-Rodriguez, Eshrak Al-Shaibani, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 6, 2021
Comparison of Outcomes After Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Lymphocyte Infusion in Allogeneic Hematopoietic Cell Transplant PatientsEshrak Al-Shaibani, Rhida Bautista, Jeffrey H Lipton, et al.
European Journal of Haematology|December 14, 2025
Eltrombopag in Treating Post-Allogeneic Hematopoietic Stem Cell Transplantation Cytopenias: Efficacy, Response Durability, and Cost Benefit of Early Drug TaperingRawan Al-Omari, Ram Vasudevan Nampoothiri, Ali Sakhdari, et al.
European Journal of Haematology|May 8, 2025
Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic/Myeloproliferative Overlap NeoplasmsNihar Desai, Sergio Rodriguez-Rodriguez, Carol Chen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 4, 2017
Long-Term Incidence of Secondary Malignancies after Allogeneic Hematopoietic Cell Transplantation: A Single-Center ExperienceFotios V Michelis, Rouslan Kotchetkov, Rebecca M Grunwald, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 16, 2022
Relationship between certain HLA alleles and the risk of cytomegalovirus reactivation following allogeneic hematopoietic stem cell transplantationShruti Prem, Mats Remberger, Ahmad Alotaibi, et al.
European Journal of Haematology|July 18, 2023
Influence of conditioning regimen intensity on outcomes post-allogeneic hematopoietic cell transplantation for acute myeloid leukemia in complete morphological remissionTommy Alfaro Moya, Jonas Mattsson, Mats Remberger, et al.
Transplantation and Cellular Therapy|March 10, 2024
Pretransplant Blinatumomab Improves Outcomes in B Cell Acute Lymphoblastic Leukemia Patients Who Undergo Allogeneic Hematopoietic Cell TransplantationAyman Sayyed, Carol Chen, Armin Gerbitz, et al.
Transplantation and Cellular Therapy|January 22, 2026
Frailty as a prognostic factor in younger adult patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantationSergio Rodriguez-Rodriguez, Maria Queralt Salas, Nihar Desai, et al.
Pageof 13